Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction (Q35957448)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction |
scientific article |
Statements
1 reference
Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction (English)
1 reference
Chikara Komiya
1 reference
Kyoichiro Tsuchiya
1 reference
Kumiko Shiba
1 reference
Yasutaka Miyachi
1 reference
Shunsaku Furuke
1 reference
Noriko Shimazu
1 reference
Shinobu Yamaguchi
1 reference
Kazuo Kanno
1 reference
Yoshihiro Ogawa
1 reference
15 March 2016
1 reference
Identifiers
1 reference